Inhibition of the PI3K/AKT signaling pathway is effective in reducing the proliferation of osteosarcoma cells, and therefore attenuation of this signaling pathway has been suggested as a target for tumour therapy. This evidence concerns the gene AKT1 and osteosarcoma.